The rapid expansion of GLP-1 receptor agonist prescriptions has strained international pharmaceutical logistics, exposing critical bottlenecks in specialized cold-chain infrastructure.
Distribution Infrastructure Shortfalls
Maintaining strict 2 to 8 degrees Celsius transport parameters across global fulfillment networks requires substantial investment in secondary packaging and real-time telemetry. Production delays remain linked to sterile fill-finish capacity limitations worldwide.